|Articles|April 11, 2022
Komodo Health and Datavant Expand Partnership
Collaboration reinforces value of connecting proprietary and third-party data.
Advertisement
Komodo Health and Datavant announced an expansion of their partnership. Together, they will enable life sciences companies to securely connect proprietary and third-party clinical trial data, specialty pharmacy data, and more to Komodo’s technology and insights platform.
Read more about the partnership expansion
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
Director of NIH Infectious Disease Institute Steps Down
5